John F. Sheridan - 06 Aug 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
PRESIDENT & CEO, Director
Signature
s/ David B. Berger , Attorney-in-Fact for John F. Sheridan
Issuer symbol
TNDM
Transactions as of
06 Aug 2021
Net transactions value
-$1,104,196
Form type
4
Filing time
10 Aug 2021, 16:44:17 UTC
Previous filing
01 Jun 2021
Next filing
31 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $8,250 +746 +12% $11.06 6,943 06 Aug 2021 Direct F1
transaction TNDM Common Stock Options Exercise $19,620 +2,180 +31% $9.00 9,123 06 Aug 2021 Direct F1
transaction TNDM Common Stock Options Exercise $45,207 +2,397 +26% $18.86 11,520 06 Aug 2021 Direct F1
transaction TNDM Common Stock Sale $272,560 -2,523 -22% $108.03 8,997 06 Aug 2021 Direct F2
transaction TNDM Common Stock Sale $306,292 -2,800 -31% $109.39 6,197 06 Aug 2021 Direct F3
transaction TNDM Common Stock Options Exercise $181,113 +9,603 +155% $18.86 15,800 09 Aug 2021 Direct F1
transaction TNDM Common Stock Sale $831,005 -7,731 -49% $107.49 8,069 09 Aug 2021 Direct F4
transaction TNDM Common Stock Sale $202,719 -1,872 -23% $108.29 6,197 09 Aug 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $8,250 +746 $11.06 0 06 Aug 2021 Common Stock 746 $11.06 Direct F6, F7
transaction TNDM Stock Option Options Exercise $19,620 +2,180 $9.00 0 06 Aug 2021 Common Stock 2,180 $9.00 Direct F7, F8
transaction TNDM Stock Option Options Exercise $45,207 +2,397 +3.4% $18.86 72,603 06 Aug 2021 Common Stock 2,397 $18.86 Direct F7, F9
transaction TNDM Stock Option Options Exercise $181,113 +9,603 +18% $18.86 63,000 09 Aug 2021 Common Stock 9,603 $18.86 Direct F7, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.00 to $108.13. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.01 to $109.71. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.96 to $107.93. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.97 to $108.65. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F6 The option vested as to One Hundred percent (100%) of the underlying shares on 04/23/2017.
F7 The expiration date for these options is 10 years from the date of grant.
F8 The option vested as to twenty-five percent (25%) of the underlying shares on 05/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.
F9 The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter.